Aphria Inc (NYSE:APHA) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the company, Marketbeat.com reports. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $14.75.
Several equities analysts have weighed in on the company. ValuEngine raised ZTE CORP/ADR from a “hold” rating to a “buy” rating in a report on Monday, April 15th. Zacks Investment Research raised Garrett Motion from a “sell” rating to a “hold” rating in a report on Friday, May 10th. Jefferies Financial Group reaffirmed a “buy” rating and issued a C$15.00 price target on shares of Aphria in a report on Friday, May 24th. Finally, Clarus Securities assumed coverage on Aphria in a report on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price target for the company.
Shares of Aphria stock traded up $0.01 on Thursday, hitting $6.30. The company had a trading volume of 10,753,500 shares, compared to its average volume of 5,445,465. The firm has a market capitalization of $1.56 billion, a PE ratio of 45.00 and a beta of 3.14. Aphria has a 1 year low of $3.75 and a 1 year high of $16.86. The stock’s 50 day simple moving average is $6.84.
Aphria (NYSE:APHA) last issued its quarterly earnings results on Monday, April 15th. The company reported ($0.15) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.04) by ($0.11). The company had revenue of $55.24 million during the quarter, compared to the consensus estimate of $41.11 million. As a group, analysts predict that Aphria will post -0.13 EPS for the current fiscal year.
Institutional investors have recently bought and sold shares of the company. Bank of America Corp DE purchased a new position in shares of Aphria in the fourth quarter worth about $2,175,000. Two Sigma Advisers LP bought a new stake in shares of Aphria in the fourth quarter worth about $129,000. Connor Clark & Lunn Investment Management Ltd. grew its stake in shares of Aphria by 1,307.8% in the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 1,057,811 shares of the company’s stock worth $9,866,000 after purchasing an additional 982,671 shares during the last quarter. G&S Capital LLC bought a new stake in shares of Aphria in the first quarter worth about $155,000. Finally, CIBC Asset Management Inc bought a new stake in shares of Aphria in the fourth quarter worth about $671,000. 8.55% of the stock is owned by hedge funds and other institutional investors.
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
Further Reading: Call Option
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.